8-K Filing

Company

BIOREGENX, INC.

Filed

January 6, 2023

Period of Report

December 29, 2022

Accession Number

0001800943-23-000001

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →